Nurix Therapeutics’ (NRIX) Buy Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued their buy rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report published on Tuesday,Benzinga reports. Needham & Company LLC currently has a $27.00 price target on the stock. NRIX has been the subject of several other research reports. Stifel Nicolaus decreased their target price on Nurix […]
Needham & Company LLC reissued their buy rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report published on Tuesday,Benzinga reports. Needham & Company LLC currently has a $27.00 price target on the stock. NRIX has been the subject of several other research reports. Stifel Nicolaus decreased their target price on Nurix […]
